NASDAQ:JAZZ

Jazz Pharmaceuticals Stock News

etoro logo Buy JAZZ
*Your capital is at risk
$230.93
+4.81 (+2.13%)
At Close: Jun 03, 2026
Jazz (JAZZ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Jazz (JAZZ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will a small change in a drug's method of delivery be enough to generate over $1 billion in new sales?
GW Henssler & Associates Ltd. cut its holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) by 16.3% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. Th
Oppenheimer analyst Esther Rajavelu maintained a Buy rating on Jazz Pharmaceuticals (JAZZ) today and set a price target of $154.00. The company's shares
Oppenheimer analyst Esther Rajavelu maintained a Buy rating on Jazz Pharmaceuticals (JAZZ – Research Report) today and set a price
Investors are excited about positive late-stage results for its narcolepsy drug.
Through six seasons, Utah Jazz coach Quin Snyder has had a wide variety of rotation pieces. Here's a look at some of his best and most interesting lineups through the years.
Oregon Public Employees Retirement Fund decreased its position in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) by 7.8% in the first quarter, according to its most recent Form 13F filing with the S
Avadel Pharmaceuticals (NASDAQ:AVDL) jumps 30% premarket on average volume in reaction to positive results from a Phase 3 clinical trial, REST-ON, evaluating lead candidate FT218, a once-nightly for
BidaskClub downgraded shares of Jazz Pharmaceuticals (NASDAQ:JAZZ) from a sell rating to a strong sell rating in a report released on Thursday morning, BidAskClub reports. Other equities analysts have
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) – Stock analysts at SVB Leerink cut their FY2020 earnings per share estimates for shares of Jazz Pharmaceuticals in a research report issued to clients and inv
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
SAN DIEGO, April 24, 2020 -- Pfenex Inc. (NYSE American: PFNX) announced today that it will report its financial results for the first quarter ended March 31, 2020, after the.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE